The Covid-19 Plasma Boom Is Over. What Did We Learn From It?
The U.S. government invested $800 million in plasma when the country was desperate for Covid-19 treatments. A year later, the program has fizzled. (Source: NYT Health)
Source: NYT Health - April 18, 2021 Category: Consumer Health News Authors: Katie Thomas and Noah Weiland Tags: your-feed-science Antibodies Blood Donation Coronavirus (2019-nCoV) Clinical Trials Government Contracts and Procurement United States Politics and Government American Red Cross Food and Drug Administration Health and Human Services Depa Source Type: news

Anti-seizure medications and risk of suicide: re-addressing the issue - Gudi SK, Jahan Q.
Although suicidal behaviour in epilepsy is a complex phenomenon, evidence suggests that suicide rates are higher amongst individuals with epilepsy than the general population. Yet, it has been a decade since the Food and Drug Administration (FDA) has passe... (Source: SafetyLit)
Source: SafetyLit - April 17, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Goodbye, PACS. Hello, MIMPS? FDA updates rules for radiology software
The U.S. Food and Drug Administration (FDA) has amended the descriptions o...Read more on AuntMinnie.comRelated Reading: FDA commissioner Hahn leaves agency FDA proposal to relax 510(k) rules on AI raises eyebrows FDA publishes action plan for medical AI software FDA relaxes rules on imaging modifications for COVID-19 FDA issues new draft guidance for medical software, CDS (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 16, 2021 Category: Radiology Source Type: news

FDA revokes emergency use authorization for monoclonal antibody Bamlanivimab
Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients. (Source: World Pharma News)
Source: World Pharma News - April 16, 2021 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

Public Notification: Triple SupremeZen Plus 3500 contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use SupremeZen Plus 3500, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Triple SupremeZen Extreme 3500 contains hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Triple SupremeZen Extreme 3500, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Thumbs Up 7 White 11K contains hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Thumbs Up 7 White 11K, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Thumbs Up 7 Black 25K contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Thumbs Up 7 Black 25K, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Shogun-X Platinum 7000 contains hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or Shogun-X Platinum 7000, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Rock Steady 72 Hours contains hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Rock Steady 72 Hours, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Premier Platinum 5000 contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Premier Platinum 5000, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: PremierZen Extreme 3000 contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use PremierZen Extreme 3000, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Original White Dragon contains hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Original White Dragon, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Krazy Night contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Krazy Night, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Kopi Jantan Tradisional Natural Herbs Coffee contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Kopi Jantan Tradisional Natural Herbs Coffee, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Imperial Platinum 2000 contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Imperial Platinum 2000, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Imperial Gold 2000 contains hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Imperial Gold 2000, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Burro en Primavera 60000 contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Burro en Primavera 60000, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: 69MODE Blue 69 contains hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use 69MODE Blue 69, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: 3 KO Gold XT contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use 3 KO Gold XT, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Will You Need a Booster Shot of the COVID-19 Vaccine?
When the first COVID-19 vaccines from Pfizer-BioNTech and Moderna were authorized by the U.S. Food and Drug Administration in December 2020, most people breathed a sigh of relief since both shots were shown to be between 94% and 95% effective in protecting from COVID-19 symptoms. But public health experts warned that nobody really knew how long the protection would last, since the longest clinical trials in people only went to a few months. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) and the chief medical advisor to President Joe Biden, suggested that additional booster ...
Source: TIME: Health - April 16, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

South Africa: Covid-19 Vaccine Roll-Out - a Dream Deferred?
[Africa In Fact] On Tuesday 13 April, Health Minister Dr Zwelini Mkhize announced the suspension of the Johnson& Johnson (J&J) vaccine roll-out to healthcare workers over fears of blood clotting. The decision comes after the Food and Drug Administration (FDA) in the United States suspended its use of the vaccine and J&J's delay in further shipments. Over 1.5 million South Africans have been infected with COVID-19 and the variant B1.351, causing the loss of over 53 000 lives. After an incredibly difficult year (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 16, 2021 Category: African Health Source Type: news

FDA probes alkaline water seller in Nevada over hepatitis and liver damage links
(Natural News) The Food and Drug Administration (FDA) is investigating Nevada-based company Real Water over accusations linking its alkaline water to hepatitis, liver damage and other health problems. On March 16, the FDA and the Southern Nevada Health District announced that they were looking into cases of acute non-viral hepatitis in five young children, which were reported to the health district... (Source: NaturalNews.com)
Source: NaturalNews.com - April 16, 2021 Category: Consumer Health News Source Type: news

Experimental antiviral for COVID-19 effective in hamster study
(NIH/National Institute of Allergy and Infectious Diseases) The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from NIH scientists. MK-4482, delivered orally, is now in human clinical trials. Remdesivir, an antiviral drug already approved by the U.S. Food and Drug Administration for use against COVID-19, must be provided intravenously, making its use primarily limited to clinical settings. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 16, 2021 Category: Infectious Diseases Source Type: news

FDA Approves Nextstellis (drospirenone and estetrol) Oral Contraceptive for Birth Control
15 April 2021, Adelaide, Australia and Liege, Belgium: Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) are very pleased to announce that the US Food and Drug Administration (FDA) has approved the New... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 15, 2021 Category: Drugs & Pharmacology Source Type: news

C.D.C. Panel Keeps Pause on Use of J & J Vaccine, Weighing Risks
An advisory committee debated the very few cases of a rare blood disorder and worried about the suspension ’s effect on global needs for a one-shot, easy-to-ship vaccine. (Source: NYT Health)
Source: NYT Health - April 15, 2021 Category: Consumer Health News Authors: Denise Grady and Carl Zimmer Tags: Blood Clots Vaccination and Immunization Coronavirus (2019-nCoV) Women and Girls Advisory Committee on Immunization Practices AstraZeneca PLC Centers for Disease Control and Prevention Johnson & Food and Drug Administration your-feed-h Source Type: news

Johnson & Johnson Statement on CDC Advisory Committee Meeting on Company COVID-19 Vaccine
NEW BRUNSWICK, N.J., April 14, 2021 – The U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) convened today to consider reports of an extremely rare disorder involving blood clots in combination with low platelets observed in a small number of individuals following vaccination with the Johnson & Johnson COVID-19 vaccine. “The safety and well-being of the people who use our products is our number one priority, and we strongly support awareness of the signs and symptoms of this extremely rare event to ensure the correct diagnosis, appropriate treatment an...
Source: Johnson and Johnson - April 15, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

FDA to Set Limits on Toxic Elements in Baby Food
WEDNESDAY, April 14, 2021 -- Limits on toxic elements such as arsenic, lead, and mercury in baby food will be proposed by the U.S. Food and Drug Administration over the next few years, but adhering to them will be voluntary for manufacturers. The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 14, 2021 Category: Pharmaceuticals Source Type: news

FDA Lifts In-Person Dispensing Requirement for Mifepristone FDA Lifts In-Person Dispensing Requirement for Mifepristone
The Food and Drug Administration has lifted in-person dispensing requirements for mifepristone when used for medical termination of early pregnancy.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - April 14, 2021 Category: Internal Medicine Tags: Ob/Gyn & Women ' s Health News Source Type: news

US military halts use of Johnson Johnson vaccine amid blood clot reports
(Natural News) The Department of Defense stopped administering Johnson & Johnson’s (J&J) Wuhan coronavirus (COVID-19) vaccine to the military on Tuesday, April 13. The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) recommended the move earlier in the day, citing reports of blood clots in people who received the jab. “At the recommendation of the FDA and CDC,... (Source: NaturalNews.com)
Source: NaturalNews.com - April 14, 2021 Category: Consumer Health News Source Type: news

Health Highlights: April 14, 2021
  FDA to Set Limits on Toxic Elements in Baby Food Limits on toxic elements such as arsenic, lead and mercury in baby food will be proposed by the U.S. Food and Drug Administration over the next few years, but adhering to them will be... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 14, 2021 Category: General Medicine Source Type: news

F.D.A. Will Allow Abortion Pills by Mail During the Pandemic
The agency said it would stop enforcing a rule requiring women to get the first of two pills in person at a medical clinic or hospital. (Source: NYT Health)
Source: NYT Health - April 14, 2021 Category: Consumer Health News Authors: Pam Belluck Tags: your-feed-science Telemedicine Coronavirus (2019-nCoV) Abortion Drugs (Pharmaceuticals) Women and Girls Food and Drug Administration Supreme Court (US) Source Type: news

Pause in Vaccinations Leads to Canceled Appointments Across States
Health departments scrambled to postpone vaccine clinics and rebook patients after the one-dose offering from Johnson& Johnson was sidelined. (Source: NYT Health)
Source: NYT Health - April 13, 2021 Category: Consumer Health News Authors: Mitch Smith and Michael D. Shear Tags: Vaccination and Immunization Johnson & Coronavirus (2019-nCoV) States (US) Rural Areas Colleges and Universities Centers for Disease Control and Prevention Food and Drug Administration United States Politics and Government Moderna Inc Source Type: news

Restrictions on Access to Abortion Pill Will Be Lifted During Pandemic
TUESDAY, April 13, 2021 -- A requirement that mifepristone abortion pills be dispensed only in person by a medical provider will be put on hold during the COVID-19 pandemic, the U.S. Food and Drug Administration says. The decision means that health... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 13, 2021 Category: Pharmaceuticals Source Type: news

Washington state pauses distribution of Johnson & Johnson vaccine
Washington state is pausing its distribution of Johnson& Johnson's Covid-19 vaccine following guidance Tuesday morning from the Food and Drug Administration and the Centers for Disease Control and Prevention. The pause is effective immediately, but it does not alter the state’s plan to allow all Washingtonians 16 years and older to be eligible for Covid-19 vaccines beginning Thursday. Six of the 6.8 million people who received the Johnson& Johnson vaccine nationwide developed a blood clot … (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 13, 2021 Category: Health Management Authors: Megan Campbell Source Type: news

Washington state pauses distribution of Johnson & Johnson vaccine
Washington state is pausing its distribution of Johnson& Johnson's Covid-19 vaccine following guidance Tuesday morning from the Food and Drug Administration and the Centers for Disease Control and Prevention. The pause is effective immediately, but it does not alter the state’s plan to allow all Washingtonians 16 years and older to be eligible for Covid-19 vaccines beginning Thursday. Six of the 6.8 million people who received the Johnson& Johnson vaccine nationwide developed a blood clot … (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 13, 2021 Category: Biotechnology Authors: Megan Campbell Source Type: news

Arizona halts Johnson & Johnson Covid-19 vaccine amid blot clot concerns
The U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration have recommended a pause in the use of the single-shot vaccine based on reported cases of a rare and severe type of blood clot. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 13, 2021 Category: Pharmaceuticals Authors: Angela Gonzales Source Type: news

J & J Vaccine and Blood Clots: A Risk, if It Exists, Is Tiny
Out of an “abundance of caution,” the F.D.A. is advising doctors to pause the Johnson& Johnson vaccine while it investigates extremely rare blood clots. (Source: NYT Health)
Source: NYT Health - April 13, 2021 Category: Consumer Health News Authors: Denise Grady and Carl Zimmer Tags: Vaccination and Immunization Blood Blood Clots Regulation and Deregulation of Industry Coronavirus (2019-nCoV) Food and Drug Administration Centers for Disease Control and Prevention AstraZeneca PLC Johnson & Source Type: news

Regeneron Antibody Cocktail Offers COVID Protection
In its statement, Regeneron said it would ask the U.S. Food and Drug Administration to expand the drug's emergency authorization use -- for high-risk people who already have COVID-19 but are not hospitalized. (Source: WebMD Health)
Source: WebMD Health - April 13, 2021 Category: Consumer Health News Source Type: news

FDA, CDC call for pause in use of Johnson & Johnson vaccine after ‘extremely rare’ cases of blood clots
The Food and Drug Administration and Centers for Disease Control and Prevention said Tuesday they are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the Johnson & Johnson vaccine. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - April 13, 2021 Category: Consumer Health News Authors: Carolyn Y. Johnson Source Type: news

U.S. Calls for Pause on Johnson & Johnson Vaccine After Blood Clotting Cases
Federal health officials call for a pause in the use of Johnson& Johnson ’s coronavirus vaccine while they study serious illnesses that have developed in six American women. (Source: NYT Health)
Source: NYT Health - April 13, 2021 Category: Consumer Health News Authors: Noah Weiland, Sharon LaFraniere and Carl Zimmer Tags: Vaccination and Immunization Coronavirus (2019-nCoV) Centers for Disease Control and Prevention Food and Drug Administration Janssen Pharmaceutica Johnson & Moderna Inc Pfizer Inc Source Type: news

Wisconsin DHS Pauses Administration of Johnson & Johnson COVID-19 Vaccine
The Wisconsin Department of Health Services (DHS) is instructing Wisconsin vaccine providers to stop administering the Johnson& Johnson COVID-19 vaccine due to a federal review of adverse side effects reported. The Centers for Disease Control (CDC) and U.S. Food and Drug Administration (FDA) issued astatementsaying six cases of a rare and severe type of blood clot called cerebral venous sinus thrombosis have been...(see release) (Source: Wisconsin DHFS Press Releases)
Source: Wisconsin DHFS Press Releases - April 13, 2021 Category: Hospital Management Authors: goodsesjfs Source Type: news

F.D.A. Will Allow Abortion Pills By Mail During the Pandemic
The agency said it would stop enforcing a rule requiring women to get the first of two pills in person at a medical clinic or hospital. (Source: NYT Health)
Source: NYT Health - April 13, 2021 Category: Consumer Health News Authors: Pam Belluck Tags: your-feed-science Telemedicine Coronavirus (2019-nCoV) Abortion Drugs (Pharmaceuticals) Women and Girls Food and Drug Administration Supreme Court (US) Source Type: news

Following key FDA approval, St. Louis medtech startup SentiAR raises $5.1M
SentiAR ’s new funding follows its receipt of 510(k) clearance from the U.S. Food and Drug Administration for its CommandEP system, which provides physicians with a holographic guidance system for invasive cardiac procedures. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 13, 2021 Category: American Health Authors: Nathan Rubbelke Source Type: news

FDA and CDC Recommend Pausing COVID-19 Vaccination With J & J-Janssen Shot While They Investigate Blood Clot Risks
The U.S. Food and Drug Administration and Centers for Disease Control and Prevention are recommending that vaccinations with the Johnson & Johnson/Janssen COVID-19 vaccine be temporarily halted while the agencies review reports of blood clots among vaccinated people. On April 13, the two government agencies issued a joint statement announcing a recommended pause as federal regulators review six cases of blood clots reported six to 13 days after the people received the single-dose vaccine. “Until that [review] process is complete, we are recommending a pause in the use of this vaccine out of an abundance of cautio...
Source: TIME: Health - April 13, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Md., Baltimore health officials halt Johnson & Johnson vaccinations amid blood clot concerns
The Maryland Department of Health and Baltimore City Health Department have directed all local providers of Covid-19 vaccinations to pause the use of Johnson& Johnson's vaccine, following reports of six "extremely rare" adverse reactions. Maryland and Baltimore joined a deluge of states and localities to call for a halt on J&J vaccine administration at the recommendations of federal officials at the Centers for Disease Control and Prevention and the Food and Drug Administration. The pause will … (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 13, 2021 Category: American Health Authors: Morgan Eichensehr Source Type: news

FDA, CDC Call for Pause in J & J COVID-19 Vaccine After Six People Develop Clots
TUESDAY, April 13, 2021 -- After six people who received the Johnson& Johnson one-dose COVID-19 vaccine developed a type of rare and severe blood clot, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention on... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 13, 2021 Category: Pharmaceuticals Source Type: news

Medtronic warns defibrillator batteries could fail early
Hundreds of thousands of Medtronic-made implantable defibrillators are at risk of failing early because of a battery problem, according to an alert issued by the Minnesota med-tech giant. The Star Tribune has a report on the warning issued earlier this year by Medtronic (NYSE: MDT) to health providers. The Food and Drug Administration on Monday published a Class I recall notice as a result of the alert. The warning applies to nearly 340,000 implanted products, including the compa ny's Evera and… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 13, 2021 Category: American Health Authors: Mark Reilly Source Type: news

Johnson & Johnson Statement on COVID-19 Vaccine
NEW BRUNSWICK, N.J., April 13, 2021– The safety and well-being of the people who use our products is our number one priority. We are aware of an extremely rare disorder involving people with blood clots in combination with low platelets in a small number of individuals who have received our COVID-19 vaccine. The United States Centers for Disease Control (CDC) and Food and Drug Administration (FDA) are reviewing data involving six reported U.S. cases out of more than 6.8 million doses administered. Out of an abundance of caution, the CDC and FDA have recommended a pause in the use of our vaccine. In addition, we have ...
Source: Johnson and Johnson - April 13, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Johnson & Johnson Statement on COVID-19 Vaccine (Updated)
NEW BRUNSWICK, N.J., April 13, 2021– The safety and well-being of the people who use our products is our number one priority. We are aware of an extremely rare disorder involving people with blood clots in combination with low platelets in a small number of individuals who have received our COVID-19 vaccine. The United States Centers for Disease Control (CDC) and Food and Drug Administration (FDA) are reviewing data involving six reported U.S. cases out of more than 6.8 million doses administered. Out of an abundance of caution, the CDC and FDA have recommended a pause in the use of our vaccine. In addition, we have ...
Source: Johnson and Johnson - April 13, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news